Trial
NCT00582582
Study of Docetaxel With Doxercalciferol or Placebo for Advanced Prostate Cancer
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Wisconsin, Madison
Collaborators
Sanofi; Genzyme, a Sanofi Company
Condition
Prostate Cancer
Intervention
Docetaxel plus doxercalciferol
Why stopped
Lack of drug supply for doxercalciferol for this study
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-12-13